首页 | 本学科首页   官方微博 | 高级检索  
     

靶向PKM2干扰质粒联合重组人血管内皮抑素治疗肺癌的实验研究
引用本文:Mao JZ,Guo WH,Shi HS,Zhao YW,Yang HS. 靶向PKM2干扰质粒联合重组人血管内皮抑素治疗肺癌的实验研究[J]. 四川大学学报(医学版), 2011, 42(3): 308-312
作者姓名:Mao JZ  Guo WH  Shi HS  Zhao YW  Yang HS
作者单位:四川大学华西医院,生物治疗国家重点实验室,成都,610041
摘    要:目的 研究丙酮酸激酶同工酶M2(PKM2)干扰质粒联合重组人血管内皮抑素是否能增强单药的抗癌作用.方法 免疫荧光检测A549细胞内PKM2蛋白表达,蛋白印迹检测PKM2质粒干扰效果.建立裸鼠皮下A549肺癌模型,将25只荷瘤小鼠随机平均分为5组:生理盐水组(NS组)、无关序列干扰质粒组(psh-Control组)、PK...

关 键 词:丙酮酸激酶同工酶M2  RNA干扰  肺癌  抗血管生成

Antitumor effect by combination of shRNA interfering plasmid targeting PKM2 with recombinant endostatin
Mao Jing-Zhi,Guo Wen-Hao,Shi Hua-Shan,Zhao Yu-Wei,Yang Han-Shuo. Antitumor effect by combination of shRNA interfering plasmid targeting PKM2 with recombinant endostatin[J]. Journal of Sichuan University. Medical science edition, 2011, 42(3): 308-312
Authors:Mao Jing-Zhi  Guo Wen-Hao  Shi Hua-Shan  Zhao Yu-Wei  Yang Han-Shuo
Affiliation:MAO Jing-zhi,GUO Wen-hao,SHI Hua-shan,ZHAO Yu-wei,YANG Han-shuo.State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu 610041,China
Abstract:Obiective To investigate the enhancement effect of the combination of shRNA interfering plasmid targeting PKM2 with recombinant Endostatin in the treatment of lung cancer.Methods Twenty five BABL/nu/nu mice bearing A549 lung cancer were divided into 5 groups(NS control,psh-Control,psh-PKM2 treated group,Endostar treated group,psh-PKM2+Endostar treated group) and treated with shRNA interfering plasmid targeting PKM2 and recombinant Endostatin respectively or in combination.The expression of PKM2 in A549 dete...
Keywords:PKM2 RNAi Lung cancer Anti-angiogenesis  
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号